Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT07099235
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18
* Able to provide informed consent
* Patient diagnosed with treatment-resistant depression
* Outpatient recommended and approved by psychiatrist for ketamine treatment
* Individuals who have previously received ECT, rTMS or any other neuromodulation can also receive ketamine
Exclusion Criteria:
* History of psychosis/comorbid psychiatric disorders/psychotic depression/dissociative syndromes, significant personality disorder, as clinically assessed by psychiatrist
* Using non-prescribed substance (e.g., cannabis) or alcohol use within the preceding 48 hours of treatment
* History of substance misuse and/or dependence, including chronic alcohol abuse
* Previous ketamine use
* Acute dementia/delirium
* Pregnancy/breastfeeding
* Previous sensitivity to ketamine or related compounds
* Unstable medical condition which may require anesthesia consult
* History of elevated intracranial pressure or cerebrovascular accident
* Recent (within 6 weeks) major cardiovascular event (such as myocardial infarction)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07099235
Study Brief:
Protocol Section:
NCT07099235